Nucleic Acids Research, 2001, Vol. 29, No. 7 1602-1607
© 2001 Oxford University Press
Phylogenetic analysis of tmRNA genes within a bacterial subgroup reveals a specific structural signature
1Department of Human Genetics, University of Utah, 15N 2030E Room 6250, Salt Lake City, UT 84112-5330, USA, 2Laboratoire de Biochimie Pharmaceutique, Faculté de Pharmacie, Université de Rennes I, UPRES Jeune Equipe 2311, IFR 97, 2 avenue du Prof. Léon Bernard, F-35043 Rennes, France and 3Unité Propre de Recherche 9002 du CNRS, Institut de Biologie Moléculaire et Cellulaire, 15 rue Descartes, F-67084 Strasbourg, France
Bacterial tmRNA mediates a trans-translation reaction, which permits the recycling of stalled ribosomes and probably also contributes to the regulated expression of a subset of genes. Its action results in the addition of a small number of C-terminal amino acids to protein whose synthesis had stalled and these constitute a proteolytic recognition tag for the degradation of these incompletely synthesized proteins. Previous work has identified pseudoknots and stemloops that are widely conserved in divergent bacteria. In the present work an alignment of tmRNA gene sequences within 13 ß-proteobacteria reveals an additional sub-structure specific for this bacterial group. This sub-structure is in pseudoknot Pk2, and consists of one to two additional stemloop(s) capped by stable GNRA tetraloop(s). Three-dimensional models of tmRNA pseudoknot 2 (Pk2) containing various topological versions of the additional sub-structure suggest that the sub-structures likely point away from the core of the RNA, containing both the tRNA and the mRNA domains. A putative tertiary interaction has also been identified.
* To whom correspondence should be addressed at: Laboratorie de Biochimie Moléculaire et Structurale, Faculté de Pharmacie, Université de Rennes, 2 Avenue du Prof. Léon Bernard, 35043 Rennes Cedex, France. Tel: +33 2 99 33 68 95; Fax: +33 2 99 33 62 08; Email: bfelden{at}univ-rennes1.fr Present address: Christian Massire, Ibis Therapeutics division of Isis Pharmaceuticals, 2292 Faraday Avenue, Carlsbad, CA 92008, USA
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Ivanova, M. Lindell, M. Pavlov, L. Holmberg Schiavone, E. G. H. Wagner, and M. Ehrenberg Structure probing of tmRNA in distinct stages of trans-translation RNA, May 1, 2007; 13(5): 713 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Sharkady and K. P. Williams A third lineage with two-piece tmRNA Nucleic Acids Res., August 23, 2004; 32(15): 4531 - 4538. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gueneau de Novoa and K. P. Williams The tmRNA website: reductive evolution of tmRNA in plastids and other endosymbionts Nucleic Acids Res., January 1, 2004; 32(90001): D104 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Gan, S. Pasquali, and T. Schlick Exploring the repertoire of RNA secondary motifs using graph theory; implications for RNA design Nucleic Acids Res., June 1, 2003; 31(11): 2926 - 2943. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Williams The tmRNA Website: invasion by an intron Nucleic Acids Res., January 1, 2002; 30(1): 179 - 182. [Abstract] [Full Text] [PDF] |
||||

